Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Predictors of inhaled corticosteroid taper failure in adults with asthma.

Cardet JC, Codispoti CD, King TS, Bacharier L, Carr T, Castro M, Chinchilli V, Dunn R, Holquing F, Engle L, Nelson K, Ortega VE, Peters M, Ramratnam S, Krishnan JA, Wechsler ME, Israel E; National Heart, Lung, and Blood Institute Asthmanet.

J Allergy Clin Immunol Pract. 2018 Sep 19. pii: S2213-2198(18)30581-6. doi: 10.1016/j.jaip.2018.05.039. [Epub ahead of print] No abstract available.

PMID:
30240889
2.

Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma.

Bleecker ER, Wechsler ME, FitzGerald JM, Menzies-Gow A, Wu Y, Hirsch I, Goldman M, Newbold P, Zangrilli JG.

Eur Respir J. 2018 Oct 18;52(4). pii: 1800936. doi: 10.1183/13993003.00936-2018. Print 2018 Oct.

PMID:
30139780
3.

Selecting the right biologic for your patients with severe asthma.

Manka LA, Wechsler ME.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):406-413. doi: 10.1016/j.anai.2018.07.033. Epub 2018 Jul 27. Review.

PMID:
30056149
4.

Susceptibility to Exacerbations in Black Adults with Asthma.

Grossman NL, Doros GD, Fandino N, Fuhlbrigge AL, Pace WD, Wechsler ME, Yawn BP, Israel E.

J Asthma. 2018 Jul 4:1-20. doi: 10.1080/02770903.2018.1486855. [Epub ahead of print]

PMID:
29969928
5.

Association of free vitamin D3 concentrations and asthma treatment failures in the VIDA Trial.

Lima JJ, Castro M, King TS, Lang JE, Ortega VE, Peters SP, Denlinger LC, Israel E, Sorkness CA, Wechsler ME, Wenzel SE, Smith LJ.

Ann Allergy Asthma Immunol. 2018 Oct;121(4):444-450.e1. doi: 10.1016/j.anai.2018.06.001. Epub 2018 Jun 14.

PMID:
29908319
6.

Bacterial biogeography of adult airways in atopic asthma.

Durack J, Huang YJ, Nariya S, Christian LS, Ansel KM, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, King TS, White SR, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Peters SP, Smith LJ, Wechsler ME, Lynch SV, Boushey HA; National Heart, Lung and Blood Institute’s “AsthmaNet”.

Microbiome. 2018 Jun 9;6(1):104. doi: 10.1186/s40168-018-0487-3.

7.

Current and Emerging Biologic Therapies for Asthma and COPD.

Wechsler ME.

Respir Care. 2018 Jun;63(6):699-707. doi: 10.4187/respcare.06322.

PMID:
29794205
8.

Identification of remission in adult-onset asthma.

Busse P, Wechsler ME.

Lancet Respir Med. 2018 Jun;6(6):417-418. doi: 10.1016/S2213-2600(18)30175-9. Epub 2018 Apr 23. No abstract available.

PMID:
29699818
9.

Revisiting the NIH Taskforce on the Research needs of Eosinophil-Associated Diseases (RE-TREAD).

Khoury P, Akuthota P, Ackerman SJ, Arron JR, Bochner BS, Collins MH, Kahn JE, Fulkerson PC, Gleich GJ, Gopal-Srivastava R, Jacobsen EA, Leiferman KM, Francesca LS, Mathur SK, Minnicozzi M, Prussin C, Rothenberg ME, Roufosse F, Sable K, Simon D, Simon HU, Spencer LA, Steinfeld J, Wardlaw AJ, Wechsler ME, Weller PF, Klion AD.

J Leukoc Biol. 2018 Jul;104(1):69-83. doi: 10.1002/JLB.5MR0118-028R. Epub 2018 Apr 19. Review.

PMID:
29672914
10.

New biologics for allergic diseases.

Manka LA, Wechsler ME.

Expert Rev Clin Immunol. 2018 Apr;14(4):285-296. doi: 10.1080/1744666X.2018.1459188. Epub 2018 Apr 10.

PMID:
29611440
11.

Mepolizumab Treatment of Pediatric Eosinophilic Granulomatosis With Polyangiitis.

Joseph MX, Jenkins LE, Wechsler ME, Davis LS.

JAMA Dermatol. 2018 Apr 1;154(4):486-487. doi: 10.1001/jamadermatol.2017.5888. No abstract available.

PMID:
29466544
12.

Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease.

Tashkin DP, Wechsler ME.

Int J Chron Obstruct Pulmon Dis. 2018 Jan 17;13:335-349. doi: 10.2147/COPD.S152291. eCollection 2018. Review.

13.

Care pathways for the selection of a biologic in severe asthma.

Bousquet J, Brusselle G, Buhl R, Busse WW, Cruz AA, Djukanovic R, Domingo C, Hanania NA, Humbert M, Menzies Gow A, Phipatanakul W, Wahn U, Wechsler ME.

Eur Respir J. 2017 Dec 7;50(6). pii: 1701782. doi: 10.1183/13993003.01782-2017. Print 2017 Dec. No abstract available.

PMID:
29217605
14.

Severe Asthma and the Primary Care Provider: Identifying Patients and Coordinating Multidisciplinary Care.

Yawn BP, Wechsler ME.

Am J Med. 2017 Dec;130(12):1479. doi: 10.1016/j.amjmed.2017.10.001. Epub 2017 Oct 3.

PMID:
28986071
15.

Novel Treatments for Airway Disease.

Wechsler ME, Akuthota P, Khoury P.

N Engl J Med. 2017 Aug 10;377(6):597-8. doi: 10.1056/NEJMc1708004. No abstract available.

PMID:
28812971
16.

Novel Treatments for Airway Disease.

Wechsler ME, Akuthota P, Khoury P.

N Engl J Med. 2017 Aug 10;377(6):597-8. doi: 10.1056/NEJMc1708004. No abstract available.

17.

Concern of underdiagnosing asthma-COPD overlap syndrome if age limit of 40 years for asthma is used.

Sin DD, Leung JM, Wechsler ME.

Eur Respir J. 2017 Aug 3;50(2). pii: 1701120. doi: 10.1183/13993003.01120-2017. Print 2017 Aug. No abstract available.

PMID:
28775052
18.

Income is an independent risk factor for worse asthma outcomes.

Cardet JC, Louisias M, King TS, Castro M, Codispoti CD, Dunn R, Engle L, Giles BL, Holguin F, Lima JJ, Long D, Lugogo N, Nyenhuis S, Ortega VE, Ramratnam S, Wechsler ME, Israel E, Phipatanakul W; Vitamin D Add-On Therapy Enhances Corticosteroid Disparities Working Group members on behalf of the AsthmaNet investigators.

J Allergy Clin Immunol. 2018 Feb;141(2):754-760.e3. doi: 10.1016/j.jaci.2017.04.036. Epub 2017 May 20.

PMID:
28535964
19.

KIT Inhibition by Imatinib in Patients with Severe Refractory Asthma.

Cahill KN, Katz HR, Cui J, Lai J, Kazani S, Crosby-Thompson A, Garofalo D, Castro M, Jarjour N, DiMango E, Erzurum S, Trevor JL, Shenoy K, Chinchilli VM, Wechsler ME, Laidlaw TM, Boyce JA, Israel E.

N Engl J Med. 2017 May 18;376(20):1911-1920. doi: 10.1056/NEJMoa1613125.

20.

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.

Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA, Merkel PA, Moosig F, Specks U, Cid MC, Luqmani R, Brown J, Mallett S, Philipson R, Yancey SW, Steinfeld J, Weller PF, Gleich GJ; EGPA Mepolizumab Study Team.

N Engl J Med. 2017 May 18;376(20):1921-1932. doi: 10.1056/NEJMoa1702079.

21.

Changing Paradigms in the Treatment of Severe Asthma: The Role of Biologic Therapies.

Katial RK, Bensch GW, Busse WW, Chipps BE, Denson JL, Gerber AN, Jacobs JS, Kraft M, Martin RJ, Nair P, Wechsler ME.

J Allergy Clin Immunol Pract. 2017 Mar - Apr;5(2S):S1-S14. doi: 10.1016/j.jaip.2016.11.029. Epub 2017 Jan 29. Review.

PMID:
28143691
22.

Race is associated with differences in airway inflammation in patients with asthma.

Nyenhuis SM, Krishnan JA, Berry A, Calhoun WJ, Chinchilli VM, Engle L, Grossman N, Holguin F, Israel E, Kittles RA, Kraft M, Lazarus SC, Lehman EB, Mauger DT, Moy JN, Peters SP, Phipatanakul W, Smith LJ, Sumino K, Szefler SJ, Wechsler ME, Wenzel S, White SR, Ackerman SJ.

J Allergy Clin Immunol. 2017 Jul;140(1):257-265.e11. doi: 10.1016/j.jaci.2016.10.024. Epub 2017 Jan 6.

23.

Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment.

Durack J, Lynch SV, Nariya S, Bhakta NR, Beigelman A, Castro M, Dyer AM, Israel E, Kraft M, Martin RJ, Mauger DT, Rosenberg SR, Sharp-King T, White SR, Woodruff PG, Avila PC, Denlinger LC, Holguin F, Lazarus SC, Lugogo N, Moore WC, Peters SP, Que L, Smith LJ, Sorkness CA, Wechsler ME, Wenzel SE, Boushey HA, Huang YJ; National Heart, Lung and Blood Institute's “AsthmaNet”.

J Allergy Clin Immunol. 2017 Jul;140(1):63-75. doi: 10.1016/j.jaci.2016.08.055. Epub 2016 Nov 10.

24.

Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taillé C, Delaval P, Cadranel J, Bonniaud P, Prévot G, Hirschi S, Gondouin A, Dunogué B, Chatté G, Briault A, Jayne D, Guillevin L, Cordier JF; the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P).

Eur Respir J. 2016 Nov;48(5):1429-1441. doi: 10.1183/13993003.00097-2016. Epub 2016 Sep 1.

25.

Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss).

Cottin V, Bel E, Bottero P, Dalhoff K, Humbert M, Lazor R, Sinico RA, Sivasothy P, Wechsler ME, Groh M, Marchand-Adam S, Khouatra C, Wallaert B, Taillé C, Delaval P, Cadranel J, Bonniaud P, Prévot G, Hirschi S, Gondouin A, Dunogué B, Chatté G, Briault C, Pagnoux C, Jayne D, Guillevin L, Cordier JF; Groupe d’Etudes et de Recherche sur les Maladies Orphelines Pulmonaires (GERM“O”P).

Autoimmun Rev. 2017 Jan;16(1):1-9. doi: 10.1016/j.autrev.2016.09.018. Epub 2016 Sep 23.

PMID:
27671089
26.

Acetaminophen versus Ibuprofen in Young Children with Mild Persistent Asthma.

Sheehan WJ, Mauger DT, Paul IM, Moy JN, Boehmer SJ, Szefler SJ, Fitzpatrick AM, Jackson DJ, Bacharier LB, Cabana MD, Covar R, Holguin F, Lemanske RF Jr, Martinez FD, Pongracic JA, Beigelman A, Baxi SN, Benson M, Blake K, Chmiel JF, Daines CL, Daines MO, Gaffin JM, Gentile DA, Gower WA, Israel E, Kumar HV, Lang JE, Lazarus SC, Lima JJ, Ly N, Marbin J, Morgan WJ, Myers RE, Olin JT, Peters SP, Raissy HH, Robison RG, Ross K, Sorkness CA, Thyne SM, Wechsler ME, Phipatanakul W; NIH/NHLBI AsthmaNet.

N Engl J Med. 2016 Aug 18;375(7):619-30. doi: 10.1056/NEJMoa1515990.

27.

What is asthma-COPD overlap syndrome? Towards a consensus definition from a round table discussion.

Sin DD, Miravitlles M, Mannino DM, Soriano JB, Price D, Celli BR, Leung JM, Nakano Y, Park HY, Wark PA, Wechsler ME.

Eur Respir J. 2016 Sep;48(3):664-73. doi: 10.1183/13993003.00436-2016. Epub 2016 Jun 23.

28.

Personalized asthma therapy in blacks-the role of genetic ancestry.

Dunn RM, Wechsler ME.

J Allergy Clin Immunol. 2016 May;137(5):1370-2. doi: 10.1016/j.jaci.2016.03.004. No abstract available.

PMID:
27155033
29.

Introduction to the 58th Annual Thomas L. Petty Aspen Lung Conference: Asthma 2015: Mechanisms to Personalized Medicine.

Kraft M, Gerber AN, Szefler SJ, Wechsler ME.

Ann Am Thorac Soc. 2016 Mar;13 Suppl 1:S23-4. doi: 10.1513/AnnalsATS.201511-767MG. No abstract available.

30.

Vitamin D3 therapy in patients with asthma complicated by sinonasal disease: Secondary analysis of the Vitamin D Add-on Therapy Enhances Corticosteroid Responsiveness in Asthma trial.

Jiao J, King TS, McKenzie M, Bacharier LB, Dixon AE, Codispoti CD, Dunn RM, Grossman NL, Lugogo NL, Ramratnam SK, Traister RS, Wechsler ME, Castro M; National Heart, Lung, and Blood Institute's AsthmaNet.

J Allergy Clin Immunol. 2016 Aug;138(2):589-592.e2. doi: 10.1016/j.jaci.2015.12.1329. Epub 2016 Mar 11. No abstract available.

31.

Vitamin D3 treatment of vitamin D-insufficient asthmatic patients does not alter immune cell function.

Reid B, Girodet PO, Boomer JS, Abdel-Gadir A, Zheng K, Wechsler ME, Bacharier LB, Kunselman SJ, King TS, Israel E, Castro M, Cernadas M, Green JM.

J Allergy Clin Immunol. 2016 Jul;138(1):286-289.e9. doi: 10.1016/j.jaci.2015.11.030. Epub 2016 Feb 10. No abstract available.

32.

Vitamin D Supplementation and the Risk of Colds in Patients with Asthma.

Denlinger LC, King TS, Cardet JC, Craig T, Holguin F, Jackson DJ, Kraft M, Peters SP, Ross K, Sumino K, Boushey HA, Jarjour NN, Wechsler ME, Wenzel SE, Castro M, Avila PC; NHLBI AsthmaNet Investigators.

Am J Respir Crit Care Med. 2016 Mar 15;193(6):634-41. doi: 10.1164/rccm.201506-1169OC.

33.

Anticholinergic vs Long-Acting β-Agonist in Combination With Inhaled Corticosteroids in Black Adults With Asthma: The BELT Randomized Clinical Trial.

Wechsler ME, Yawn BP, Fuhlbrigge AL, Pace WD, Pencina MJ, Doros G, Kazani S, Raby BA, Lanzillotti J, Madison S, Israel E; BELT Investigators.

JAMA. 2015 Oct 27;314(16):1720-30. doi: 10.1001/jama.2015.13277.

PMID:
26505596
34.

Recommendations for the use of bronchial thermoplasty in the management of severe asthma.

Dheda K, Koegelenberg CF, Esmail A, Irusen E, Wechsler ME, Niven RM, Bateman ED, Chung KF; Assembly on Interventional Pulmonology of the South African Thoracic Society.

S Afr Med J. 2015 Sep 14;105(9):726-32. doi: 10.7196/SAMnew.8207.

PMID:
26428967
35.

Indications for the use of bronchial thermoplasty in severe asthma.

Dheda K, Koegelenberg CF, Esmail A, Irusen E, Wechsler ME, Niven RM, Chung KF, Bateman ED.

S Afr Med J. 2015 Sep 18;105(10):808-9. doi: 10.7196/SAMJnew.8208.

36.

Reducing asthma attacks in patients with severe asthma: The role of bronchial thermoplasty.

Dunn R, Wechsler ME.

Allergy Asthma Proc. 2015 Jul-Aug;36(4):242-50. doi: 10.2500/aap.2015.36.3851. Review.

PMID:
26108080
37.

Rebuttal Comments from Dr. Dunn and Dr. Wechsler.

Dunn R, Wechsler ME.

Allergy Asthma Proc. 2015 Jul-Aug;36(4):240-1. doi: 10.2500/aap.2015.36.0620. No abstract available.

38.

Impact of Age and Sex on Response to Asthma Therapy.

Dunn RM, Lehman E, Chinchilli VM, Martin RJ, Boushey HA, Israel E, Kraft M, Lazarus SC, Lemanske RF, Lugogo NL, Peters SP, Sorkness CA, Szefler S, Wechsler ME; NHLBI Asthma Clinical Research Network.

Am J Respir Crit Care Med. 2015 Sep 1;192(5):551-8. doi: 10.1164/rccm.201503-0426OC.

39.

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management.

Groh M, Pagnoux C, Baldini C, Bel E, Bottero P, Cottin V, Dalhoff K, Dunogué B, Gross W, Holle J, Humbert M, Jayne D, Jennette JC, Lazor R, Mahr A, Merkel PA, Mouthon L, Sinico RA, Specks U, Vaglio A, Wechsler ME, Cordier JF, Guillevin L.

Eur J Intern Med. 2015 Sep;26(7):545-53. doi: 10.1016/j.ejim.2015.04.022. Epub 2015 May 9.

40.

Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials.

Castro M, Zangrilli J, Wechsler ME, Bateman ED, Brusselle GG, Bardin P, Murphy K, Maspero JF, O'Brien C, Korn S.

Lancet Respir Med. 2015 May;3(5):355-66. doi: 10.1016/S2213-2600(15)00042-9. Epub 2015 Feb 23. Erratum in: Lancet Respir Med. 2015 Apr;3(4):e15. Lancet Respir Med. 2016 Oct;4(10 ):e50.

PMID:
25736990
41.

Bronchial thermoplasty: ready for prime time--the evidence is there!

Castro M, Cox G, Wechsler ME, Niven RM.

Chest. 2015 Feb;147(2):e73-e74. doi: 10.1378/chest.14-2296. No abstract available.

42.

LTC4 synthase polymorphism modifies efficacy of botanical seed oil combination in asthma.

Kazani S, Arm JP, Boyce J, Chhay H, Dutile S, Wechsler ME, Govindarajulu U, Ivester P, Ainsworth HC, Sergeant S, Chilton FH, Israel E.

Springerplus. 2014 Nov 6;3:661. doi: 10.1186/2193-1801-3-661. eCollection 2014.

43.

Asthma: pathogenesis and novel drugs for treatment.

Olin JT, Wechsler ME.

BMJ. 2014 Nov 24;349:g5517. doi: 10.1136/bmj.g5517. Review.

PMID:
25420994
44.

Novel targeted therapies for eosinophil-associated diseases and allergy.

Radonjic-Hoesli S, Valent P, Klion AD, Wechsler ME, Simon HU.

Annu Rev Pharmacol Toxicol. 2015;55:633-56. doi: 10.1146/annurev-pharmtox-010814-124407. Epub 2014 Oct 17. Review.

45.

Reply: safety of short-acting β-agonists not a barrier to making asthma rescue and controller medications available over the counter.

Gerald JK, Wechsler ME, Martinez FD.

Ann Am Thorac Soc. 2014 Sep;11(7):1162-3. doi: 10.1513/AnnalsATS.201407-318LE. No abstract available.

PMID:
25237999
46.

Lipoxin generation is related to soluble epoxide hydrolase activity in severe asthma.

Ono E, Dutile S, Kazani S, Wechsler ME, Yang J, Hammock BD, Douda DN, Tabet Y, Khaddaj-Mallat R, Sirois M, Sirois C, Rizcallah E, Rousseau E, Martin R, Sutherland ER, Castro M, Jarjour NN, Israel E, Levy BD; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

Am J Respir Crit Care Med. 2014 Oct 15;190(8):886-97. doi: 10.1164/rccm.201403-0544OC.

47.

Comment on: International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma.

Wechsler ME, Cox GP.

Eur Respir J. 2014 Jul;44(1):267. doi: 10.1183/09031936.00043514. No abstract available.

48.

Asthma medications should be available for over-the-counter use: pro.

Gerald JK, Wechsler ME, Martinez FD.

Ann Am Thorac Soc. 2014 Jul;11(6):969-74. doi: 10.1513/AnnalsATS.201404-139OI. Review.

PMID:
24964037
49.

The placebo effect in asthma.

Dutile S, Kaptchuk TJ, Wechsler ME.

Curr Allergy Asthma Rep. 2014 Aug;14(8):456. doi: 10.1007/s11882-014-0456-2. Review.

50.

Getting control of uncontrolled asthma.

Wechsler ME.

Am J Med. 2014 Nov;127(11):1049-59. doi: 10.1016/j.amjmed.2014.05.006. Epub 2014 May 17. Review.

PMID:
24844737

Supplemental Content

Loading ...
Support Center